Skip to main content
Premium Trial:

Request an Annual Quote

BGI Opens Genomics Research Center in Copenhagen


BGI has opened a genomics research center in Copenhagen's Bio Science Park that will be equipped with 10 Illumina HiSeq 2000 sequencers.

The goal of the center is to establish collaborations in genomics research and its applications to health care, agriculture, and bioenergy.

The center will kick off with two main initiatives: a cancer vaccine project and the 1% Danes' Genome Project.

The cancer vaccine project aims to use sequencing to identify unknown cancer pathogens and develop and patent commercial vaccines.

The 1% Dane's Genome Project is a collaboration between BGI and the University of Copenhagen, Aarhus University, Aalborg University, Herlev Hospital, and the Technical University of Denmark. The effort will sequence the genomes of 50,000 Danish citizens in order to build a database for disease research.

The research center is part of BGI Europe's efforts, which was established in May 2010 in Copenhagen, but until now has been primarily a sales and marketing effort (IS 7/5/2011).

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.